|
|
||||||||
Department of Medicine, and Department of Obstetrics and Gynecology, University of Vermont, Burlington, Vermont 05405
Controversy exists regarding the relative
importance of adiposity, physical fitness, and physical activity in the
regulation of insulin-stimulated glucose disposal. To address this
issue, we measured insulin-stimulated glucose disposal
[mg · kg fat-free mass
(FFM)
1 · min
1; oxidative and
nonoxidative components] in 45 nondiabetic, nonobese, premenopausal
women (mean ± SD; 47 ± 3 yr) by use of hyperinsulinemic euglycemic clamp (40 mU · m
2 · min
1) and
[6,6-2H2]glucose dilution techniques. We also
measured body composition, abdominal fat distribution, thigh muscle fat
content, maximal oxygen consumption
(
O2 max), and physical activity energy expenditure (2H218O kinetics) as
possible correlates of glucose disposal.
O2 max was the strongest correlate of
glucose disposal (r = 0.63, P < 0.01),
whereas whole body and abdominal adiposity showed modest associations
(range of r values from
0.32 to
0.46, P < 0.05 to P < 0.01). A similar pattern of
correlations was observed for nonoxidative glucose disposal. None of
the variables measured correlated with oxidative glucose disposal. The
relationship of
O2 max to glucose
disposal persisted after statistical control for FFM, percent body fat,
and intra-abdominal fat (r = 0.40, P < 0.01). In contrast, correlations of total and regional adiposity
measures to insulin sensitivity were no longer significant after
statistical adjustment for
O2 max.
O2 max was the only variable to enter
stepwise regression models as a significant predictor of total and
nonoxidative glucose disposal. Our results highlight the importance of
O2 max as a determinant of glucose
disposal and suggest that it may be a stronger determinant of variation
in glucose disposal than total and regional adiposity in nonobese,
nondiabetic, premenopausal women.
aerobic fitness; body composition; body fat distribution; euglycemic clamp
This article has been cited by other articles:
![]() |
M. J. Toth, B. C. Cooper, R. E. Pratley, A. Mari, D. E. Matthews, and P. R. Casson Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1035 - E1045. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Yeo, N. P. Hays, R. A. Dennis, P. M. Kortebein, D. H. Sullivan, W. J. Evans, and R. H. Coker Fat Distribution and Glucose Metabolism in Older, Obese Men and Women J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2007; 62(12): 1393 - 1401. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Toth, C. K. Sites, D. E. Matthews, and P. R. Casson Ovarian suppression with gonadotropin-releasing hormone agonist reduces whole body protein turnover in women Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E483 - E490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Martin, Z. Q. Wang, X. H. Zhang, D. Wachtel, J. Volaufova, D. E. Matthews, and W. T. Cefalu Chromium Picolinate Supplementation Attenuates Body Weight Gain and Increases Insulin Sensitivity in Subjects With Type 2 Diabetes Diabetes Care, August 1, 2006; 29(8): 1826 - 1832. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-B. Nguyen-Duy, M. Z. Nichaman, T. S. Church, S. N. Blair, and R. Ross Visceral fat and liver fat are independent predictors of metabolic risk factors in men Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1065 - E1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ross, J. Aru, J. Freeman, R. Hudson, and I. Janssen Abdominal adiposity and insulin resistance in obese men Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E657 - E663. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |